Tag Archives: Finds

CDC study finds coronavirus rarely kills children, but minorities at higher risk

Children from ethnic and racial minorities, those with underlying health conditions and those between the ages of 18 and 20 are more likely to die, a CDC-led research team wrote in a study published Tuesday in the agency’s Morbidity and Mortality Weekly Report. The report also showed just how unusual it is for children and… Read More »

Hospital margins hit hard by pandemic, but CARES Act provided huge relief, Moody’s finds

Dive Brief: A new report from Moody’s Investors Service concluded that non-profit and public hospital margins have declined but liquidity has improved during the COVID-19 pandemic, primarily due to advanced Medicare payments under the relief provisions of the Coronavirus Aid, Relief, and Economic Security Act. However, overall cash flow slumped. The acuity of inpatients also… Read More »

Young adults hardest hit by loneliness during pandemic, study finds

As psychologists worry that the coronavirus pandemic is triggering a loneliness epidemic, new Harvard research suggests feelings of social isolation are on the rise and that those hardest hit are older teens and young adults. In the recently released results of a study conducted last October by researchers at Making Caring Common, 36 percent of… Read More »

Meta-analysis finds no real difference in safety and effectiveness between tenofovir formulations

There are no real differences between tenofovir formulations – tenofovir disoproxil fumarate (TDF) and tenofovir alafenamide (TAF) – in terms of viral suppression and bone and renal safety, according to a systematic review and meta-analysis published in AIDS. The newer formulation of the drug (TAF) only showed superiority in terms of efficacy, and then to a modest… Read More »

People with NNRTI resistance have poorer responses to dolutegravir, South African study finds

People with HIV who already have resistance to a non-nucleoside reverse transcriptase inhibitor (NNRTI) when they start first-line antiretroviral treatment containing the integrase inhibitor dolutegravir were less likely to achieve viral suppression, a large clinical trial in South Africa has reported. NNRTI resistance has not been shown to affect responses to dolutegravir-based treatment previously. The… Read More »